Viewing Study NCT00636805

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2026-02-07 @ 8:35 PM
Study NCT ID: NCT00636805
Status: TERMINATED
Last Update Posted: 2014-04-01
First Post: 2008-02-27
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab
Sponsor: Duke University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Brain Neoplasm, Primary View
None Brain Neoplasms, Malignant View
None Aloxi View